The Fas counterattack: A molecular mechanism of tumor immune privilege

被引：57
|
作者：
OConnell, J
Bennett, MW
OSullivan, GC
Collins, JK
Shanahan, F
机构：
[1] NATL UNIV IRELAND UNIV COLL CORK,DEPT MED,CORK,IRELAND
[2] NATL UNIV IRELAND UNIV COLL CORK,DEPT SURG,CORK,IRELAND
来源：
MOLECULAR MEDICINE | 1997年 / 3卷 / 05期
关键词：
D O I：
10.1007/BF03401808
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：294 / 300
页数：7
相关论文
共 50 条
  • [41] The Fas counterattack - Another mode of lymphoepithelial communication
    OConnell, J
    OSullivan, G
    Collins, JK
    Shanahan, F
    GASTROENTEROLOGY, 1996, 110 (04) : A981 - A981
  • [42] Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma -: Indications of apoptotic tumor counterattack
    Zietz, C
    Rumpler, U
    Stürzl, M
    Löhrs, U
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (03): : 963 - 970
  • [43] Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
    Saas, P
    Walker, PR
    Hahne, M
    Quiquerez, AL
    Schnuriger, V
    Perrin, G
    French, L
    Van Meir, EG
    deTribolet, N
    Tschopp, J
    Dietrich, PY
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06): : 1173 - 1178
  • [44] Profiling tumor counterattack: Do fas ligand - Containing microvesicles reduce anticancer immunity? Commentary
    Bohana-Kashtan, O
    Civin, CI
    CLINICAL CANCER RESEARCH, 2005, 11 (03) : 968 - 970
  • [45] ELIMINATING TUMOR IMMUNE PRIVILEGE THROUGH IMMUNE CHECKPOINT CYTOREDUCTION
    Winkler, Michelle
    Curran, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A350 - A350
  • [46] The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma
    Bennett, MW
    O'Connell, J
    O'Sullivan, GC
    Brady, C
    Roche, D
    Collins, JK
    Shanahan, F
    JOURNAL OF IMMUNOLOGY, 1998, 160 (11): : 5669 - 5675
  • [47] Influence of Immune Privilege on Ocular Tumor Development
    McKenna, Kyle C.
    Chen, Peter W.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2010, 18 (02) : 80 - 90
  • [48] A vision of cell death: Fas ligand and immune privilege 10 years later
    Ferguson, Thomas A.
    Griffith, Thomas S.
    IMMUNOLOGICAL REVIEWS, 2006, 213 : 228 - 238
  • [49] Membrane Fas ligand activates innate immunity and terminates ocular immune privilege
    Gregory, MS
    Repp, AC
    Holhbaum, AM
    Saff, RR
    Marshak-Rothstein, A
    Ksander, BR
    JOURNAL OF IMMUNOLOGY, 2002, 169 (05): : 2727 - 2735
  • [50] Role of Fas ligand in conferring immune privilege to non-lymphoid cells
    Guller, S
    UTERUS: ENDOMETRIUM AND MYOMETRIUM, 1997, 828 : 268 - 272
12345